Description
Myrislignan has anti-inflammatory and anti-cancer activities it inhibited NF-kappaB signalling pathway activation inhibited the proliferation of A549 cells in a dose- and time-dependent manner it also significantly induced apoptosis and cell cycle arrest in A549 cells